Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Ambrisentan
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 51, 84, 85, 86, 88, 210, 211 💬
2Ambrisentan - high dose
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
3Ambrisentan - low dose
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
4Ambrisentan 5 mg
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 88 💬
5Ambrisentan 5 mg film-coated tablets
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
6Ambrisentan 5mg film-coated tablets [marketed product]
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
7Ambrisentan plus Spironolactone
(Volibris (TN))
2件: Ambrisentan (Volibris),
Spironolactone
2件: Spironolactone ,
Ambrisentan (Volibris (TN)) 💬
2件: EDNRA,
NR3C2 💬
8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
8Ambrisentan Tablet
(Volibris (TN))
1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
9Bosentan, Ambrisentan
(Volibris (TN))
2件: Ambrisentan (Volibris),
Bosentan
3件: Bosentan ,
Ambrisentan (Volibris (TN)),
Bosentan 💬
2件: EDNRA,
EDNRB 💬
9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
10Tadalafil and ambrisentan upfront combination therapy
(Volibris (TN))
2件: Ambrisentan (Volibris),
Tadalafil
2件: Tadalafil ,
Ambrisentan (Volibris (TN)) 💬
2件: EDNRA,
PDE5A 💬
9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 86 💬
11Volibris1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 51, 85, 86, 88 💬
12VOLIBRIS 10 mg comprimidos recubiertos con película1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
13VOLIBRIS 5 mg comprimidos recubiertos con película1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
14VOLIBRIS® (ambrisentan)1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
15VOLIBRIS™ tablets1件: Ambrisentan (Volibris)1件: Ambrisentan (Volibris (TN)) 💬1件: EDNRA 💬7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬